title
date
Written by:
desc
content
Press
No items found.
Latest press
No items found.
Press
/
.svg)
.png)
.png)
The first surgeon-centric imaging system designed For the localization of visually enhanced markers placed at the time of biopsy for a simplified treatment and workflow.
We are View Point Medical and we are pioneering Minimally Invasive Localization
Peter Klemm has over 25 years of leadership experience, building companies and creating markets for novel, high-value products.
He has held numerous leadership positions in pharmaceuticals, medical device and molecular diagnostics at NuVasive, Applied Proteomics, Predictive Biosciences, GeneOhm Sciences, Becton Dickinson, Jomed, Gruenenthal GmbH and Hoechst AG (now Sanofi).
Dr. Klemm qualified in veterinary medicine and holds a PhD in pharmacology. He completed his post-doctoral fellowship at the William Harvey Research Institute in London with Sir John Vane.
.svg)
Bill Blair was the co-founder and CTO of RF Surgical Systems, acquired by Medtronic.
Prior to RF Surgical, he held leadership and development roles at Bell-Atlantic and innovative early phase tech startups in electronics and telecom companies.
He holds a BS in electrical engineering and applied physics from Case Western Reserve University and has authored numerous patents.
Dr. Jeffrey Port is a Professor of Cardiothoracic Surgery and Attending Surgeon at New York Presbyterian – Weill Cornell Medical Center in New York.
He specializes in minimally invasive lung and esophageal cancer surgery, and lung volume reduction in emphysema patients.
Dr. Port is also the co-founder of RF Surgical Systems, acquired by Medtronic.
Josh Baltzell has over 20 years of experience in the healthcare industry.
He currently serves as Venture Partner as Sightline Ventures and Split Rock Partners, and was previously with St. Paul Venture Capital.
Josh has prior experience in investment banking at Piper Jaffray, and has held various marketing and business development roles at Boston Scientific.
Mayah Klain has over ten years of experience in the medical device industry, with specific focus on bringing disruptive technologies to market.
Prior to joining View Point, she specialized in patient safety on the global marketing team in Medtronic’s minimally invasive therapies group.
Mayah also served in both upstream and downstream marketing roles at RF Surgical Systems, the leading retained sponge prevention company through its acquisition by Medtronic in 2015.
Tom is a seasoned regulatory affairs expert with over 40 years in MedTech and extensive experience navigating the FDA with successful regulatory approvals, clearances, and compliance certifications.
Peter Klemm has over 25 years of leadership experience, building companies and creating markets for novel, high-value products.
He has held numerous leadership positions in pharmaceuticals, medical device and molecular diagnostics at NuVasive, Applied Proteomics, Predictive Biosciences, GeneOhm Sciences, Becton Dickinson, Jomed, Gruenenthal GmbH and Hoechst AG (now Sanofi).
Dr. Klemm qualified in veterinary medicine and holds a PhD in pharmacology. He completed his post-doctoral fellowship at the William Harvey Research Institute in London with Sir John Vane.
Bill Blair was the co-founder and CTO of RF Surgical Systems, acquired by Medtronic.
Prior to RF Surgical, he held leadership and development roles at Bell-Atlantic and innovative early phase tech startups in electronics and telecom companies.
He holds a BS in electrical engineering and applied physics from Case Western Reserve University and has authored numerous patents.
Dr. Jeffrey Port is a Professor of Cardiothoracic Surgery and Attending Surgeon at New York Presbyterian – Weill Cornell Medical Center in New York.
He specializes in minimally invasive lung and esophageal cancer surgery, and lung volume reduction in emphysema patients.
Dr. Port is also the co-founder of RF Surgical Systems, acquired by Medtronic.
Josh Baltzell has over 20 years of experience in the healthcare industry.
He currently serves as Venture Partner as Sightline Ventures and Split Rock Partners, and was previously with St. Paul Venture Capital.
Josh has prior experience in investment banking at Piper Jaffray, and has held various marketing and business development roles at Boston Scientific.
Mayah Klain has over ten years of experience in the medical device industry, with specific focus on bringing disruptive technologies to market.
Prior to joining View Point, she specialized in patient safety on the global marketing team in Medtronic’s minimally invasive therapies group.
Mayah also served in both upstream and downstream marketing roles at RF Surgical Systems, the leading retained sponge prevention company through its acquisition by Medtronic in 2015.
Tom is a seasoned regulatory affairs expert with over 40 years in MedTech and extensive experience navigating the FDA with successful regulatory approvals, clearances, and compliance certifications.
